DELM identifies structural changes in lesions

Guttman, Cheryl
August 2000
Dermatology Times;Aug2000, Vol. 21 Issue 8, p14
Trade Publication
Reports on the use of digital epiluminescence microscopy in evaluating melanocytic skin lesions in patients with multiple atypical nevi. Morphologic modifications of melanomas; Characteristics of melanomas; Differentiation of melanomas from benign melanocytic lesions.


Related Articles

  • Dermatoscopy gives diagnostic confidence. Nash, Karen // Dermatology Times;Aug2000, Vol. 21 Issue 8, p11 

    Reports on the effectiveness of the dermatoscope in diagnosing melanoma. Procedure followed by dermatologists in the United States in deciding whether to use or not to use the dermatoscope; Attitude of dermatologists; Preference of dermatologists to do a biopsy on a lesion.

  • Cancer Fighter. Gawel, Richard; Konish, Nancy // Electronic Design;06/14/99, Vol. 47 Issue 12, p64B 

    Introduces T-Scan 2000 device used in tumor detection on women breast developed by TransScan Medical Inc. in Ramsey, New Jersey. Description of the T-Scan 200 device; Efficacy and limitations of the device; Condition for the approval of the device; Contact information.

  • SENORX GETS 510(K) CLEARANCE FOR SINGLE STEP BIOPSY DEVICE.  // Biotech Equipment Update;Oct2002, p1 

    Reports that medical device company SenoRx Inc. has received 510 (k) clearance from U.S. Food and Drug Administration to market its Single Step breast biopsy device for the diagnosis of breast cancer. Uses of the device; Investors in the company; Other devices for which the company has received...

  • EXACT SCIENCES REPORTS NET LOSS OF 7.6 MILLION FOR FIRST QTR.  // Biotech Financial Reports;Jun2002, p6 

    Reports on financial results of cancer diagnostic equipment company Exact Sciences Corp. for the first quarter of 2002. Net loss reported by the company for the quarter; Factors which resulted in losses for the company; Recognition given to scientists and clinicians of the company by various...

  • Cancer Catchers. Deans, Alan // Bulletin with Newsweek;10/16/2001, Vol. 119 Issue 6297, p12 

    Details the development of Truscan, a cancer detection device. Conduction of independent trials in six countries to win approval from European regulators; Description of Truscan; Number of individual tests for the accuracy of Truscan. INSET: Healthy profits, by Alan Deans..

  • Testing of BCC detection device begins in Canada. Guttman, Cheryl // Dermatology Times;Feb2000, Vol. 21 Issue 2, p8 

    Evaluates the SCD-1 Skin Cancer Detection System from Biomax Technologies Inc. in Canada. Use of the device in delineating and defining basal cell carcinoma borders; Differentiation between normal skin and basal cell carcinoma; Analysis of tumor borders with natural room light; Removal of...

  • Early Oral Cancer Check. Bright, Jennifer // Prevention;Oct2001, Vol. 53 Issue 10, p164 

    Reports on a cancer check called OralCDx that allows dentists to take a quick, painless sample of suspicious mouth lesions which is then analyzed by computer.

  • Bloomberg.  // Business News New Jersey;4/17/96, Vol. 9 Issue 8, p56 

    Reports that Immunomedics's CEA-Scan, a cancer diagnostic product, has moved closer to the United States market after meeting agency requirements of the Food and Drug Administration.

  • As I See It. Dodgson, Gregory E. V. // Grand Rapids Business Journal;09/05/2000, Vol. 18 Issue 36, p30 

    Analyzes the profit prospects of stocks of Matritech, a cancer detection company. Use of proprietary proteomics discovery processes to identify and commercialize proteins as cancer markers; Completion of preliminary testing with a colon cancer patients.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics